1-4 of 4
Ping Yu
Close
Sort by
Journal Articles

NK-cell activation by LIGHT triggers tumor-specific CD8 + T-cell immunity to reject established tumors

Zusen Fan, Ping Yu, Yang Wang, Yugang Wang, May Lynne Fu, Wenhua Liu, Yonglian Sun, Yang-Xin Fu
Journal: Blood
Blood (2006) 107 (4): 1342–1351.
https://doi.org/10.1182/blood-2005-08-3485
Published: 2006
Journal Articles

In Vivo Chemotherapy Protection and Efficacy of Multidrug Resistance (MDR-1) Gene Transfer in a Patient with Refractory Non-Hodgkin’s Lymphoma (NHL).

Pamela S. Becker, MD, PhD, Adrianne N. Hanks, BA, Ying Ping Yu, MD, Ann Marie Ceredona, MT(ASCP), MA, William V. Walsh, MD, Judith L. O’Donnell, BS, Christopher Baum, MD, Lynn Kallander, MT(ASCP), BS, Philip A. Lowry, MD, T.J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD
Journal: Blood
Blood (2005) 106 (11): 3054.
https://doi.org/10.1182/blood.V106.11.3054.3054
Published: 2005
Journal Articles

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Pamela S. Becker, MD, PhD, Ying Ping Yu, MD, Ann Marie Ceredona, MT, MA, William V. Walsh, MD, Judith L. O’Donnell, BS, RN, Christopher Baum, MD, Lynn Kallander, BS, Philip A. Lowry, MD, T. J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD
Journal: Blood
Blood (2004) 104 (11): 5278.
https://doi.org/10.1182/blood.V104.11.5278.5278
Published: 2004
Journal Articles

Treatment of B-Cell Lymphoma With Chimeric IgG and Single-Chain Fv Antibody–Interleukin-2 Fusion Proteins

Shih-Jen Liu, Yuh-Pyng Sher, Chou-Chik Ting, Kuang-Wen Liao, Cheng-Ping Yu, Mi-Hua Tao
Journal: Blood
Blood (1998) 92 (6): 2103–2112.
https://doi.org/10.1182/blood.V92.6.2103
Published: 1998